Alliance Pharma PLC (LSE:APH) - Share price

Stock Report

Alliance Pharma PLC APH

Latest Morningstar Commentary
DateAuthor Headline
14/11/2013Emma Wall Healthy Income from Pharmaceutical Stocks
Using the Morningstar QuickRank tool we reveal the pharma stocks paying the highest dividend yield - and how our analysts value the companies' shares

Latest Company News

Previous Stories...
06/01/202013:58LSEBlock Listing Six Monthly ReturnBLR
03/01/202007:00LSETotal Voting RightsTVR
06/12/201916:42LSEGrant of Options to DirectorsDSH
05/12/201917:17LSENotification of Major HoldingsHOL
05/12/201915:00LSEDirector's DealingDSH
03/12/201912:07LSETotal Voting RightsTVR
27/11/201907:00LSEReturn of Xonvea Licensing RightsMSC
05/11/201915:51LSETotal Voting RightsTVR
09/10/201911:14LSEDirector's DealingDSH
03/10/201907:00LSETotal Voting RightsTVR
24/09/201907:00LSEInterim ResultsIR
03/09/201915:26LSETotal Voting RightsTVR
05/08/201907:00LSENotification of Interim ResultsNOR
02/08/201910:04LSETotal Voting RightsTVR
17/07/201907:00LSEHalf Year Trading UpdateTST
01/07/201912:39LSETotal Voting RightsTVR
01/07/201908:00LSEBlock Listing Six Monthly ReturnBLR
01/07/201907:00LSEDirectorate ChangeBOA
04/06/201911:58LSETotal Voting RightsTVR
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2020 Morningstar. All rights reserved.